KL4 LIMITED

Company number 14670677 ·

Active

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

KL4 LIMITED - Analysis Report

Company Number: 14670677

Analysis Date: 2025-07-29 20:17 UTC

Financial Health Assessment Report for KL4 LIMITED


1. Financial Health Score: C

Explanation:
KL4 LIMITED shows early-stage company characteristics with modest net assets and a low equity base. The company has positive net current assets but carries significant director loan liabilities. The overall financial status suggests moderate financial stability but with notable caution due to high related-party debt and limited accumulated reserves. This positions the company in a "fair but vulnerable" category, warranting close monitoring and proactive measures.


2. Key Vital Signs

Metric Value (£) Interpretation
Fixed Assets 28,991 Represents investment in long-term assets; healthy for a micro-entity.
Current Assets 11,828 Working capital resources such as cash and debtors.
Current Liabilities 3,684 Short-term obligations; low relative to current assets.
Net Current Assets 8,144 Positive working capital — a sign of liquidity and operational health.
Creditors > 1 Year 35,500 Large long-term liability, entirely due to a director loan.
Net Assets 1,085 Very low equity indicating thin capitalization.
Shareholders' Funds 1,085 Mirrors net assets; limited retained earnings or capital.
Employees 3 Small team consistent with micro-company status.
Director Loan 35,500 High reliance on director financing; risk factor for solvency.

3. Diagnosis: What the Financial Data Reveals

KL4 LIMITED is a newly incorporated micro-entity operating in the take-away food sector. The company has successfully built a base of fixed assets, likely equipment or premises-related, which supports its operations. The current assets exceed current liabilities, showing good short-term liquidity — a "healthy pulse" indicating the company can meet immediate obligations.

However, the significant "symptom of distress" is the large director loan (£35,500) recorded as a creditor due after more than one year. This indicates the company is relying heavily on internal financing to fund its operations and assets, which if not managed carefully, could stress cash flow or ownership dynamics.

The extremely low net assets and shareholders’ funds (£1,085) reflect minimal equity cushion. This thin capitalization means the company has limited buffer to absorb losses or unexpected expenses, akin to a patient with low immunity.

The exemption from audit and micro-entity accounting treatment is normal and appropriate, but it also means less external scrutiny, so internal financial discipline is critical.


4. Recommendations: Path to Financial Wellness

  • Strengthen Equity Base: Consider raising additional share capital or retaining profits to improve net assets and reduce financial vulnerability.
  • Manage Director Loan: Formalize repayment terms or restructure the director loan to avoid liquidity bottlenecks and potential governance issues.
  • Cash Flow Monitoring: Implement robust cash flow forecasting to ensure ongoing liquidity and avoid short-term distress.
  • Growth Strategy: Focus on increasing turnover and profitability to build reserves and reduce reliance on director funding.
  • Cost Control: Keep fixed costs and overheads under control to maintain positive net current assets.
  • Regular Financial Reviews: Schedule quarterly financial health check-ups to identify emerging risks early and adjust strategy accordingly.

Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 29 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.